Financhill
Back

NovoCure Stock Predictions

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 62.9% based on the past 7 years of stock performance.
  • NovoCure has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $90.90. The Score for NVCR is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 62.9% based on the past 7 years of stock performance.

NovoCure Stock Rating

Buy
74
NovoCure (NVCR) is a Buy

Is NovoCure overpriced?

  • NovoCure has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Medical Instruments & Supplies
Sector:
Healthcare
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
120.03
52-Week Low:
56.39

Prediction Charts

Market Cap:
9.54B
Price in USD:
90.90
Volume:
542.46K
Beta:
0.99

Technical Analysis

SMA50:
81.48
SMA100:
79.35
SMA200:
77.22
52-Wk Change:
51.12%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price isĀ 90.90 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-9 102.66 91.25 103.69 90.53
Jan-10 91.50 93.03 94.03 86.40
Jan-11 94.33 96.70 99.82 93.34
Jan-12 96.80 95.70 99.76 94.48
Jan-13 95.65 93.99 96.45 93.51
Jan-17 93.00 92.26 94.12 89.52
Jan-18 93.32 92.83 96.02 91.58
Jan-19 84.69 88.03 89.99 84.36
Jan-20 88.86 88.49 89.17 86.98
Jan-23 88.29 88.01 89.30 87.00
Jan-24 87.87 87.66 89.49 86.27
Jan-25 86.66 90.16 90.31 85.91
Jan-26 91.50 90.05 93.99 88.92
Jan-27 90.04 90.90 91.69 88.72

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.09 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.